Skip to main content
OpenTrials
Completed

NCT Number: NCT07617701

Cross-cultural Adaptation and Validation of the French Version of the Athletic Disordered Eating Scale (ADE)

Assessing disordered eating is crucial in athlete health monitoring. However, existing tools are not tailored to athletes' specific needs.

In 2024, Buckley et al. developed the Athletic Disordered Eating (ADE) scale, a 17-item tool validated through athlete interviews and expert review. ADE is the first screening tool for athletes using both classical psychometrics and item response theory. Recent studies confirm its effectiveness in diverse athlete populations.

With approval from Prof. Regina Belski, we aim to validate a French version (ADE-Fr) through cross-cultural adaptation and psychometric analysis, including adolescent athletes (15+). We hypothesize that ADE-Fr will retain the original structure with strong validity and reliability.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Athlete Eating Disorder Prevention Eating Disorders Symptoms

Age range

15 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Caen Normandy

Caen, Basse-Normandie, 14000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 15 to 70 years
  • Patients who engage in more than 6 hours of sports per week
  • Patients who have answered all questions on the questionnaire
  • Patients undergoing an eating behavior assessment as part of sports medical monitoring
  • For minors, this applies to those under regulatory medical surveillance.

Exclusion criteria

  • Unfilled or incomplete questionnaires
  • Participants who did not receive the information sheet

Treatment and study plan

The French version of the Athletic Disordered Eating (ADE-Fr) Scale

Diagnostic Test

Participants will complete the French version of the Athletic Disordered Eating (ADE-Fr) scale, alongside standard evaluations including the Eating Attitudes Test-26 for criterion validity.

Primary outcomes

  1. The Athletic Disordered Eating (ADE) Scale (French version, ADE-Fr)

    Time frame: At enrollment, single time point

    The ADE scale consists of 17 items, each with five response options: never (0), rarely (1), sometimes (2), often (3), and always (4). The total score reflects the level of disordered eating (DE) risk: minimal or none (<25), moderate (25-32), high (33-44), and very high (≥45).

Secondary outcomes

  1. Eating Attitudes Test-26 (EAT-26)

    Time frame: At enrollment, single time point

    The EAT-26 screens for eating disorder risk by evaluating attitudes, feelings, and behaviors related to eating. It includes 26 self-report questions on general eating habits and 5 additional questions on risky behaviors.

  2. Type of sport

    Time frame: At enrollment, single time point

    The type of sport practiced as the main sport

  3. Volume of sport

    Time frame: At enrollment, single time point

    The amount or volume (hours per week) of sport practiced weekly

  4. Test-retest reliability for the Athletic Disordered Eating (ADE) Scale (French version, ADE-Fr)

    Time frame: Two measurements at a 5-day interval

    The reproducibility of the scale will be tested in a subgroup of 25 participants to assess the consistency of the results over time.

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Acronym: ADE-Fr

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jun 1, 2026
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.